Wellington Management Group
ACOR

Wellington Management Group’s Acorda Therapeutics ACOR Stock Holding History

Wellington Management Group’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,800
Closed -$620K – 2157
2019
Q3 		$620K Sell
1,800
-48
-3% -$26.1K ﹤0.01% 1836
2019
Q2 		$1.7M Hold
1,848
– – ﹤0.01% 1657
2019
Q1 		$2.95M Hold
1,848
– – ﹤0.01% 1518
2018
Q4 		$3.46M Sell
1,848
-354
-16% -$770K ﹤0.01% 1481
2018
Q3 		$5.19M Buy
2,202
+19
+0.9% +$58.8K ﹤0.01% 1472
2018
Q2 		$7.52M Buy
2,183
+396
+22% +$1.21M ﹤0.01% 1368
2018
Q1 		$5.07M Buy
1,787
+1,066
+148% +$3.19M ﹤0.01% 1481
2017
Q4 		$1.85M Sell
721
-18
-2% -$51.2K ﹤0.01% 1763
2017
Q3 		$2.1M Buy
739
+62
+9% +$163K ﹤0.01% 1711
2017
Q2 		$1.6M Sell
677
-50
-7% -$99.1K ﹤0.01% 1764
2017
Q1 		$1.83M Buy
727
+107
+17% +$308K ﹤0.01% 1763
2016
Q4 		$1.4M Sell
620
-3,551
-85% -$8.44M ﹤0.01% 1783
2016
Q3 		$10.4M Sell
4,171
-2,210
-35% -$6.59M ﹤0.01% 1159
2016
Q2 		$19.5M Sell
6,381
-8,229
-56% -$26.8M 0.01% 953
2016
Q1 		$46.4M Sell
14,610
-40
-0.3% -$166K 0.01% 699
2015
Q4 		$75.2M Buy
14,650
+157
+1% +$686K 0.02% 556
2015
Q3 		$46.1M Sell
14,493
-354
-2% -$1.37M 0.01% 697
2015
Q2 		$59.4M Sell
14,847
-1,231
-8% -$4.76M 0.02% 664
2015
Q1 		$64.2M Buy
16,078
+2,477
+18% +$11.3M 0.02% 658
2014
Q4 		$66.7M Buy
13,601
+4,383
+48% +$18.8M 0.02% 639
2014
Q3 		$37.5M Sell
9,218
-1,032
-10% -$3.87M 0.01% 819
2014
Q2 		$41.5M Buy
10,250
+435
+4% +$1.77M 0.01% 805
2014
Q1 		$44.6M Sell
9,815
-184
-2% -$744K 0.01% 776
2013
Q4 		$35M Sell
9,999
-1,379
-12% -$5.38M 0.01% 835
2013
Q3 		$46.8M Buy
11,378
+976
+9% +$4.2M 0.01% 720
2013
Q2 		$41.2M Buy
+10,402
New +$42.8M 0.01% 751

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wellington Management Group's ACOR Position: Q4 2019 in Review

Wellington Management Group sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 1,800 shares — an estimated $620K sold.

Wellington Management Group first reported a position in ACOR in Q2 2013 and held it in 26 quarters. The position peaked at $75.2M in Q4 2015. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Wellington Management Group reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Wellington Management Group sold 1,800 Acorda Therapeutics shares in Q4 2019, an estimated $620K.
  • Wellington Management Group first reported a position in Acorda Therapeutics in Q2 2013 and held it in 26 quarters.
  • Wellington Management Group's Acorda Therapeutics position peaked at $75.2M in Q4 2015.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Wellington Management Group's 13F filing for Q4 2019, filed 11 Feb 2020.